Category

Insights
2022: A Year in Review

2022: A Year in Review

As we slowly emerged from our COVID caves of 2020-2021, this year brought great excitement to Medlior.  We helped industry bring life-changing innovations to market, and we increased our stakeholder collaboration.

Men’s Mental Health: A Silent Crisis

Men’s Mental Health: A Silent Crisis

November is men’s health awareness month – and some of the less-often-talked about health issues affecting men are about their mental health. The Canadian Mental Health Association is calling this a “silent crisis, a sleeper issue”.

CADTH RWE Framework

CADTH RWE Framework

I had the pleasure of attending the The Canadian Association for Population Therapeutics annual conference in Toronto, Canada. The program was titled “Embracing Change and Uncertainty to Improve the Health of Canadians” and it was kicked-off with a townhall session on Canadian RWE Initiatives…

Early Diagnosis of Alzheimer’s Disease Using AI Techniques in Primary Care

Early Diagnosis of Alzheimer’s Disease Using AI Techniques in Primary Care

Alzheimer’s disease (AD) is a degenerative neurological disease with progressive death of brain cells, eventually leading to death.1,2 It is the most prevalent irreversible dementia, marked by deterioration of memory, judgement, and reasoning and worsening of mood, behaviour, communication, and function to perform daily activities.1 With longer life expectancy and an aging population, the burden of AD on the quality of life of patients and their family and caregivers is increasing.

Canada’s Rare Disease Strategy – What is it and why do we care?

Canada’s Rare Disease Strategy – What is it and why do we care?

Approximately 1 in 12 Canadians, mostly children, are affected by a rare disorder. Patients with rare diseases face many challenges, including misdiagnosis, limited treatment, and difficulty accessing innovative therapies even when they are available. Implementing the Rare Disease Strategy will not necessarily cost Canadians more. Earlier diagnosis and correct treatments can lead to reduced unnecessary surgeries, organ transplants, and visits to multiple specialists, resulting in savings for the health system and taxpayers.

Value-based Health Care 

Value-based Health Care 

Reflecting over the last 2 years The pandemic has shown us the crucial imperative of having highly functioning and interconnected healthcare systems. Everything comes at a cost which is why it is so important to achieve the greatest value for money. But what is value...

Looking Forward To 2022 

Looking Forward To 2022 

Following the unprecedented year of 2020, 2021 brought increased global awareness to our field of work. The pandemic has brought terms such as ‘epidemiology’, ‘efficacy’ and ‘real word evidence’ into lay language and the vital role of health outcomes research has...

Looking Back On 2021

Looking Back On 2021

As the reality of living amongst a global pandemic set in across the world over the past year, a key highlight of 2021 was undoubtedly the rollout of life saving vaccines from AstraZeneca, Pfizer, Johnson and Johnson, and Moderna. At Medlior, this was also a year of...